Add BrightSurf on Google Email

Scientific consortium established by national institutes of health provides real-time risk assessment of SARS-CoV-2 variants on immune protection

The SAVE program, a NIH initiative, provides real-time risk assessment of SARS-CoV-2 variants on immune protection. It uses a coordinated approach to identify and curate data about these variants, their impact on immunity, and their effects on vaccine protection.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeCommentary/editorial·DateMar 31, 2022

Should COVID-19 vaccines and drugs be not-for-profit?

The COVID-19 pandemic has highlighted the need for equitable access to vaccines and medicines. Mohga Kamal-Yanni argues that waiving intellectual property rules can help share knowledge and technology, ensuring universal access. In contrast, Thomas Cueni emphasizes the importance of financial incentives for biopharmaceutical innovation.

SourceBMJ Group·JournalThe BMJ·DateMar 30, 2022

We need to increase MMR uptake urgently

Low MMR vaccine uptake is being blamed for a decline in protective immunity, with only 95% coverage needed to prevent outbreaks. Experts urge parents and healthcare professionals to improve awareness and uptake of the vaccine.

SourceBMJ Group·JournalThe BMJ·DateMar 30, 2022

Medical students demonstrate efficacy of COVID-19 vaccines in multiple immunocompromised patient groups

A group of medical students from NUS Yong Loo Lin School of Medicine conducted a meta-analysis on the efficacy of COVID-19 vaccines in immunocompromised patients. They found that immunocompromised patients produced significantly lower antibodies after vaccination, with only a third achieving seroconversion after two doses.

The great and powerful Dr. Oz? Alternative health media consumption and vaccine views

A new study by researchers from the Annenberg Public Policy Center finds that exposure to alternative health media can affect beliefs about consequential health-care issues like vaccination. After Dr. Mehmet Oz endorsed the MMR (measles-mumps-rubella) vaccine on a March 2019 episode of “The Dr. Oz Show,” significantly more people in hi...

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalJournal of Communication·TypeSurvey·DateMar 29, 2022

IgA antibodies seem to protect unvaccinated against COVID-19

A University of Gothenburg study found that IgA antibodies present in the respiratory tract protected healthcare workers from contracting COVID-19. The research, published in the European Journal of Immunology, suggests that these antibodies may play a crucial role in preventing severe illness and hospitalization.

SourceUniversity of Gothenburg·JournalEuropean Journal of Immunology·TypeObservational study·DateMar 24, 2022

Novel therapeutic strategy shows promise against pancreatic cancer

Scientists at Albert Einstein College of Medicine have developed a novel therapeutic strategy that uses bacteria to deliver tetanus toxin into pancreatic tumor cells, inducing an immune response and killing the cancer. The treatment has shown promise in reducing cancer metastases by 87% and increasing mouse lifespan by 40%.

SourceAlbert Einstein College of Medicine·JournalScience Translational Medicine·TypeObservational study·DateMar 23, 2022

Evidence is currently insufficient to show omicron variant has a shorter period of infectiousness compared with previous variants

The omicron variant's infectiousness period is uncertain, with evidence suggesting it may not be shorter than previous variants. Dr Marjolein Irwin-Knoester recommends a maximum of 7-day isolation for most cases, striking a balance between virus infectivity and community acceptance.

Changing beliefs is critical to sustaining high levels of vaccination

A new study by Santa Fe Institute researchers Katrin Schmelz and Samuel Bowles found that people's opposition to vaccines quadrupled when mandated, but many switched to pro-vaccination as they became more convinced of the vaccines' effectiveness. To increase vaccination rates, policymakers need to focus on building trust and changing h...

SourceSanta Fe Institute·JournalProceedings of the National Academy of Sciences·TypeSurvey·DateMar 22, 2022

Booster for immune protection after Corona infection

Researchers at Max Planck Institute of Molecular Physiology discovered that vaccination after COVID-19 recovery increases neutralizing antibody levels by up to five times, providing better protection against current coronavirus variants. The study involved 140 volunteers and showed that antibody levels remained high even after 300 days.

SourceMax Planck Institute of Molecular Physiology·JournalEuropean Journal of Immunology·TypeExperimental study·DateMar 21, 2022

mRNA-based Covid-19 vaccines are safe for high-risk patients, shows study

A new study published in Frontiers in Oncology has shown that mRNA-based Covid-19 vaccines are well-tolerated by high-risk patients with impaired immunity. The trial enrolled 566 patients and found no evidence of increased adverse events or interference with treatment, reassuring vaccine-hesitant immunocompromised individuals.

SourceFrontiers·JournalFrontiers in Oncology·TypeObservational study·DateMar 17, 2022

COVID vaccination is also recommended for people with cancer

A comprehensive review of over 60 studies confirms that COVID vaccination is around 80% effective in protecting people with cancer against SARS-CoV-2 infection. The mRNA vaccines were found to be the most effective, and multiple vaccinations are recommended for better protection.

SourceLeibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute -·JournalNature Reviews Clinical Oncology·TypeLiterature review·DateMar 14, 2022

Project helps East St. Louis residents overcome barriers to COVID-19 testing, vaccination

A project in East St. Louis, Illinois is using a public health model to deploy effective interventions for medically and socially vulnerable residents to obtain COVID-19 testing, treatment, and vaccination services. Critical dialogues are being used to engage participants in discussions about their beliefs on preventive behaviors.

Moffitt study finds cancer patients do benefit from COVID-19 vaccination

A Moffitt study found that COVID-19 vaccination led to seroconversion in most cancer patients, but with differing antibody response rates among various cancer types and treatments. Patients with blood cancers had lower seroconversion rates compared to those with solid tumors, highlighting the need for personalized immune responses.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalJAMA Oncology·TypeObservational study·DateMar 10, 2022

Immigrants are twice as likely to fear being targets of stigma during the COVID-19 pandemic in Canada

A new study from the University of Toronto reveals that immigrants are twice as likely to fear being targeted of stigma during the COVID-19 pandemic in Canada compared to Canadian-born residents. Additionally, migrants expressed greater health concerns related to vaccines and accessing healthcare during the early days of the pandemic.

SourceUniversity of Toronto·JournalJournal of Immigrant and Minority Health·TypeData/statistical analysis·DateMar 10, 2022

Pandemic protection

A new study published in BMJ Evidence-Based Medicine found that vaccines are most effective when distributed in areas with the highest baseline risks. The researchers used absolute risk reduction to guide the equitable distribution of COVID-19 vaccines, prioritizing counties and states with lower numbers needed to vaccinate (NNV).

SourceUniversity of New Mexico Health Sciences Center·JournalBMJ Evidence-Based Medicine·TypeData/statistical analysis·DateMar 8, 2022

THE LANCET INFECTIOUS DISEASES: Large U.S. study confirms most mRNA COVID-19 vaccine side effects are mild and temporary

A large US study found that 92% of reported adverse events following mRNA COVID-19 vaccination were non-serious, with most side effects being mild and decreasing substantially after one day. The study also found that less than 1% of participants reported seeking medical care after vaccination.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·TypeMeta-analysis·DateMar 7, 2022

Case study goes inside how Rutgers managed the pandemic

The case study examines Rutgers' comprehensive universitywide plan, leveraging internal expertise to develop a swift and effective response. The university required vaccinations for students, promoting resilience and community, and demonstrated the role institutions can play in addressing significant issues.

SourceRutgers University·JournalElectronic Journal of Knowledge Management·TypeCase study·DateMar 3, 2022